Cipher Pharmaceuticals Inc. (TSX:CPH)
Canada · Delayed Price · Currency is CAD 16.72
-0.17 (-0.98%)
Jun 9, 2026, 3:59 PM EST
Cipher Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 50.94 | 50.45 | 33.36 | 21.16 | 20.68 | 21.94 | |
Revenue Growth (YoY) | 28.90% | 51.22% | 57.66% | 2.36% | -5.78% | 1.55% |
Cost of Revenue | 9.36 | 10.03 | 9.26 | 4.07 | 3.99 | 3.68 |
Gross Profit | 41.58 | 40.42 | 24.1 | 17.09 | 16.68 | 18.26 |
Selling, General & Admin | 14.6 | 16.66 | 14.95 | 5.69 | 4.55 | 5.11 |
Depreciation & Amortization Expenses | 7.22 | 7.23 | 4.02 | 1.23 | 0.99 | - |
Research & Development | - | 0.02 | - | 0.14 | 0.1 | 0.09 |
Other Operating Expenses | -0.06 | - | - | - | - | 1.25 |
Total Operating Expenses | 21.76 | 23.91 | 18.97 | 7.06 | 5.63 | 6.45 |
Operating Income | 19.82 | 16.51 | 5.13 | 10.03 | 11.05 | 11.81 |
Interest Income | - | - | 0.33 | 1.87 | 0.46 | - |
Other Non-Operating Income (Expense) | 0.41 | 0.52 | -2.51 | 0.78 | -0.04 | -0.75 |
Total Non-Operating Income (Expense) | 0.41 | 0.52 | -2.18 | 2.65 | 0.43 | -0.75 |
Pretax Income | 20.23 | 17.03 | 2.96 | 12.68 | 11.48 | 11.06 |
Provision for Income Taxes | -10.64 | -10.17 | -8.59 | -7.7 | -15.16 | 3.3 |
Net Income | 30.87 | 27.2 | 11.55 | 20.38 | 26.64 | 7.76 |
Net Income to Common | 30.87 | 27.2 | 11.55 | 20.38 | 26.64 | 7.76 |
Net Income Growth | 233.85% | 135.59% | -43.36% | -23.48% | 243.34% | 76.88% |
Shares Outstanding (Basic) | 26 | 25 | 25 | 25 | 27 | 27 |
Shares Outstanding (Diluted) | 26 | 26 | 25 | 25 | 27 | 27 |
Shares Change (YoY) | 1.85% | 2.70% | -0.79% | -5.25% | - | -1.96% |
EPS (Basic) | 1.21 | 1.07 | 0.47 | 0.82 | 1.05 | 0.29 |
EPS (Diluted) | 1.18 | 1.05 | 0.46 | 0.80 | 1.03 | 0.29 |
EPS Growth | 227.78% | 128.26% | -42.50% | -22.33% | 255.17% | 81.25% |
Free Cash Flow | - | 0 | 19.5 | 15.98 | 10.64 | 13.81 |
Free Cash Flow Growth | - | - | 22.05% | 50.11% | -22.95% | 18.26% |
Free Cash Flow Per Share | - | - | 0.77 | 0.63 | 0.40 | 0.51 |
Gross Margin | 81.63% | 80.12% | 72.24% | 80.77% | 80.69% | 83.21% |
Operating Margin | 38.91% | 32.73% | 15.39% | 47.41% | 53.45% | 53.82% |
Profit Margin | 60.60% | 53.91% | 34.60% | 96.32% | 128.83% | 35.36% |
FCF Margin | - | 0.00% | 58.45% | 75.50% | 51.48% | 62.95% |
EBITDA | 19.82 | 16.51 | 9.15 | 11.26 | 12.04 | 12.51 |
EBITDA Margin | 38.91% | 32.73% | 27.43% | 53.21% | 58.23% | 57.01% |
EBIT | 19.82 | 16.51 | 5.13 | 10.03 | 11.05 | 11.81 |
EBIT Margin | 38.91% | 32.73% | 15.39% | 47.41% | 53.45% | 53.82% |
Effective Tax Rate | -52.62% | -59.68% | -290.69% | -60.74% | -132.04% | 29.85% |